How much does tirzepatide cost without insurance?
Tirzepatide is a once-weekly injectable medication, and like most GLP-1/GIP treatments, its price can vary widely depending on whether it's brand-name or compounded, which pharmacy fills it, and what's bundled into the monthly price.
Without insurance, brand-name tirzepatide (sold as Zepbound®) commonly runs anywhere from the mid-$300s to over $1,000 a month depending on dose, and that number often climbs as your provider titrates you upward. Compounded tirzepatide through a telehealth provider is typically less expensive, but pricing structures vary just as much from company to company.
This guide breaks down what actually drives the cost, what a fair price should include, and how Renlo's flat-rate model compares.
| Renlo (compounded) | Typical brand-name (self-pay) | |
|---|---|---|
| Starting monthly price | $269/mo | $349–$499/mo |
| Price at a higher dose | $269/mo (unchanged) | Often $500–$650+/mo |
| 3-month plan | $233/mo | Not typically offered |
| Provider consultation | Included | Often billed separately |
| Supplies (needles, alcohol wipes) | Included | Often billed separately |
| Shipping | Free, expedited | Varies by pharmacy |
| Ongoing care team access | Included, unlimited | Varies by provider |
What actually drives the price of tirzepatide
The single biggest factor is whether you're getting brand-name tirzepatide (Zepbound®, manufactured by Eli Lilly) or compounded tirzepatide prepared by a licensed 503A pharmacy. Compounded versions are generally the more affordable route because they aren't priced like a patented, mass-marketed retail drug - but "compounded" isn't a single price point either, since different telehealth companies bundle very different things into their monthly number.
Beyond brand vs. compounded, three things move the price the most: the dose you're prescribed (higher doses generally cost more from most providers, though not from Renlo), whether the price includes your provider visit and supplies or charges for those separately, and whether shipping is free or billed per order.
How Renlo's pricing compares to brand-name tirzepatide
Zepbound®'s self-pay pricing through LillyDirect has historically started around $349–$499 a month for the starting dose, and climbed as high as $650 or more per month at the higher maintenance doses used later in treatment. That means the price you sign up for is rarely the price you end up paying once your provider titrates you up.
Renlo's compounded tirzepatide is $269/month on the monthly plan, or $233/month on the 3-month plan - and that number does not change as your dose increases. Whether you're on your first dose or your highest, the price is identical. This is a price comparison for informational purposes only; brand-name pricing changes over time and should be confirmed directly with the manufacturer. Renlo's compounded tirzepatide is not FDA-approved and is not a generic, substitute, or equivalent of Zepbound®.
What's included in Renlo's price
Renlo's monthly price covers your provider consultation and ongoing care, your medication, injection supplies, free expedited shipping, and unlimited messaging with your care team for dosing questions or side effects. There's no membership fee layered on top and no insurance required to get started.
Insurance, FSA, and HSA
Renlo does not bill insurance directly, so your price is the same whether or not you have coverage. Many insurance plans still don't cover GLP-1 medications for weight management, or only cover them under narrow conditions, which is part of why self-pay telehealth has become common.
Because tirzepatide is prescribed by a licensed provider to treat a medical condition, it is often FSA or HSA eligible - but eligibility depends on your specific plan, and some plans require a Letter of Medical Necessity from your provider. Check with your plan administrator before assuming coverage, and keep your itemized receipt in case it's requested.
Why price shouldn't change with dose
Many GLP-1 programs - brand-name and compounded alike - increase your monthly cost as your dose increases over time, since higher doses use more medication. Renlo prices tirzepatide the same at every dose level, so your budget stays predictable through the entire course of treatment, from your first injection through maintenance dosing.
Frequently asked questions
Do I need insurance for tirzepatide through Renlo?
No. Renlo does not require insurance. Pricing is transparent and confirmed before treatment begins, regardless of your coverage.
Does the price increase as my dose increases?
No. Renlo offers the same price at every dose, so your monthly cost stays consistent throughout treatment, unlike many programs that raise the price as you titrate up.
Is tirzepatide FSA or HSA eligible?
Often, yes, since it's prescribed by a licensed provider for a medical condition - but eligibility depends on your specific plan, and some plans require a Letter of Medical Necessity. Check with your plan administrator to confirm.
How does Renlo's price compare to brand-name Zepbound?
Brand-name tirzepatide self-pay pricing has typically started around $349–$499 a month and increased at higher doses. Renlo's compounded tirzepatide is $269/month flat (or $233/month on the 3-month plan) at every dose. Renlo's compounded tirzepatide is not FDA-approved and is not a generic, substitute, or equivalent of any branded product.
What's included in the monthly price?
Your provider consultation and ongoing care, medication, injection supplies, free expedited shipping, and access to your care team for questions or dose adjustments.
Can I estimate my own savings?
Yes - use the free GLP-1 cost calculator to compare Renlo's pricing against typical brand-name and compounded alternatives based on your dose.
This page is for general informational purposes only and is not medical advice. Suitability for any treatment is determined after a licensed provider reviews your intake.